Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.48 AUD | -4.00% | -2.04% | -46.67% |
23/05 | Zelira Therapeutics Receives Third-Tranche of Funding for HOPE Clinical Trials | MT |
15/04 | Zelira Therapeutics Receives AU$919,000 Funding Under Australian Government’s R&D Tax Incentive Scheme | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeAnnual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-46.67% | 3.61M | |
+12.30% | 118B | |
+12.15% | 106B | |
-8.14% | 23.4B | |
-1.69% | 21.78B | |
-10.60% | 18.09B | |
-41.25% | 16.72B | |
-15.33% | 15.97B | |
+5.80% | 14.03B | |
+28.03% | 11.67B |
- Stock Market
- Equities
- ZLD Stock
- News Zelira Therapeutics Limited
- Transcript : Zelira Therapeutics Limited - Shareholder/Analyst Call